Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura

Wintrobe's clinical hematology.

1981 • 1,192 citations

Postmarketing Surveillance and Adverse Drug Reactions

1999 • 342 citations

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

1993 • 272 citations

Limitations and strengths of spontaneous reports data

1998 • 222 citations

Introducing MEDWatch

1993 • 174 citations

Rossi's Principles of Transfusion Medicine

2016 • 167 citations

Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients

2000 • 147 citations

Clinical presentation of heparin-induced thrombocytopenia.

1998 • 147 citations

Use of Rh Immune Globulin: ASCP Practice Parameter

1998 • 88 citations

Safety profile of WinRho anti-D.

1998 • 50 citations

Scientific Basis of Transfusion Medicine: Implications for Clinical Practice

1994 • 38 citations

Problems Associated With Passively Transfused Blood Group Alloantibodies

1998 • 38 citations

How the US Food and Drug Administration defines and detects adverse drug events

2001 • 31 citations

Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin

2000 • 27 citations

Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency

2002 • 25 citations

Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura

2002 • 24 citations

Intravenous Anti-D Immune Globulin-Induced Intravascular Hemolysis in Epstein–Barr Virus-Related Thrombocytopenia

2001 • 21 citations

Adverse Event Reporting with Selective Serotonin-Reuptake Inhibitors

2003 • 20 citations

Acute renal failure after intravenous anti‐D immune globulin in an adult with immune thrombocytopenic purpura

2003 • 20 citations

Intravenous Rh immune globulin for treating immune thrombocytopenic purpura

2001 • 14 citations

Epidemiologists and adverse event data—a challenge to the field

1999 • 8 citations

Sequelae of treatment of ITP with anti-D (Rh0) immunoglobulin

2000 • 7 citations

After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP)

2004 • 7 citations

Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.

2000 • 3 citations